James E. Flynn 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:20 pm Purchase | 2021-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | James E. Flynn | 5,882,353 4.500% | 5,882,353 (New Position) | Filing |